(+)-schisandrin B multiple interactions ISO RGD:620856 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GTF2IRD1 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:733836 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GTF2IRD1 mRNA CTD PMID:22079256 1,2-dibromoethane decreases expression EXP 6480464 Ethylene Dibromide results in decreased expression of GTF2IRD1 protein CTD PMID:22434383 1,2-dimethylhydrazine affects expression EXP 6480464 1, 2-Dimethylhydrazine affects the expression of GTF2IRD1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF2IRD1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of GTF2IRD1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GTF2IRD1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GTF2IRD1 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GTF2IRD1 mRNA CTD PMID:21889950 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GTF2IRD1 mRNA CTD PMID:17942748 2-methylcholine affects expression ISO RGD:733836 6480464 beta-methylcholine affects the expression of GTF2IRD1 mRNA CTD PMID:21179406 2-nitrotoluene decreases expression EXP 6480464 2-nitrotoluene results in decreased expression of GTF2IRD1 protein CTD PMID:22434383 3H-1,2-dithiole-3-thione decreases expression ISO RGD:620856 6480464 1, 2-dithiol-3-thione results in decreased expression of GTF2IRD1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GTF2IRD1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:620856 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of GTF2IRD1 mRNA CTD PMID:36041667 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of GTF2IRD1 mRNA CTD PMID:28973697 Aflatoxin B2 alpha increases methylation ISO RGD:733836 6480464 aflatoxin B2 results in increased methylation of GTF2IRD1 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:733836 6480464 Tretinoin results in decreased expression of GTF2IRD1 mRNA CTD PMID:33167477 ammonium chloride affects expression ISO RGD:620856 6480464 Ammonium Chloride affects the expression of GTF2IRD1 mRNA CTD PMID:16483693 amosite asbestos decreases methylation ISO RGD:733836 6480464 Asbestos, Amosite results in decreased methylation of GTF2IRD1 promoter CTD PMID:29626692 amphetamine decreases expression ISO RGD:620856 6480464 Amphetamine results in decreased expression of GTF2IRD1 mRNA CTD PMID:30779732 atrazine affects methylation ISO RGD:620856 6480464 Atrazine affects the methylation of GTF2IRD1 gene CTD PMID:28931070 Benoxacor decreases expression EXP 6480464 benoxacor results in decreased expression of GTF2IRD1 mRNA CTD PMID:34850242 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of GTF2IRD1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of GTF2IRD1 exon, Benzo(a)pyrene results in decreased methylation of GTF2IRD1 intron CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:733836 6480464 Benzo(a)pyrene affects the methylation of GTF2IRD1 5' UTR, Benzo(a)pyrene affects the methylation of GTF2IRD1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:733836 6480464 Benzo(a)pyrene results in decreased expression of GTF2IRD1 mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:733836 6480464 7 more ... CTD PMID:19150397 , PMID:26238291 benzo[e]pyrene affects methylation ISO RGD:733836 6480464 benzo(e)pyrene affects the methylation of GTF2IRD1 intron CTD PMID:30157460 bisphenol A increases expression ISO RGD:620856 6480464 bisphenol A results in increased expression of GTF2IRD1 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:620856 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of GTF2IRD1 mRNA CTD PMID:36041667 bisphenol A decreases methylation ISO RGD:733836 6480464 bisphenol A results in decreased methylation of GTF2IRD1 gene CTD PMID:31601247 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of GTF2IRD1 promoter CTD PMID:27334623 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GTF2IRD1 mRNA CTD PMID:26063408 bisphenol F multiple interactions ISO RGD:620856 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of GTF2IRD1 mRNA CTD PMID:36041667 C60 fullerene increases expression ISO RGD:620856 6480464 fullerene C60 results in increased expression of GTF2IRD1 mRNA CTD PMID:19167457 caffeine decreases phosphorylation ISO RGD:733836 6480464 Caffeine results in decreased phosphorylation of GTF2IRD1 protein CTD PMID:35688186 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of GTF2IRD1 mRNA CTD PMID:25620056 cisplatin decreases expression ISO RGD:733836 6480464 Cisplatin results in decreased expression of GTF2IRD1 mRNA CTD PMID:27392435 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of GTF2IRD1 mRNA CTD PMID:23811191 cobalt dichloride decreases expression ISO RGD:733836 6480464 cobaltous chloride results in decreased expression of GTF2IRD1 mRNA CTD PMID:19376846 coumestrol multiple interactions ISO RGD:733836 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GTF2IRD1 mRNA CTD PMID:19167446 crocidolite asbestos decreases methylation ISO RGD:733836 6480464 Asbestos, Crocidolite results in decreased methylation of GTF2IRD1 promoter CTD PMID:29626692 Cuprizon increases expression ISO RGD:620856 6480464 Cuprizone results in increased expression of GTF2IRD1 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:733836 6480464 Cyclosporine results in increased expression of GTF2IRD1 mRNA CTD PMID:20106945 , PMID:25562108 cyclosporin A decreases methylation ISO RGD:733836 6480464 Cyclosporine results in decreased methylation of GTF2IRD1 promoter CTD PMID:27989131 dibutyl phthalate decreases expression ISO RGD:620856 6480464 Dibutyl Phthalate results in decreased expression of GTF2IRD1 mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:733836 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:733836 6480464 Doxorubicin results in decreased expression of GTF2IRD1 mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO RGD:733836 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GTF2IRD1 mRNA CTD PMID:19167446 epoxiconazole affects expression EXP 6480464 epoxiconazole affects the expression of GTF2IRD1 mRNA CTD PMID:35436446 flutamide increases expression ISO RGD:620856 6480464 Flutamide results in increased expression of GTF2IRD1 mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF2IRD1 mRNA CTD PMID:22206623 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of GTF2IRD1 mRNA CTD PMID:25629700 geraniol increases expression ISO RGD:733836 6480464 geraniol results in increased expression of GTF2IRD1 mRNA CTD PMID:27683099 ketamine increases expression ISO RGD:620856 6480464 Ketamine results in increased expression of GTF2IRD1 mRNA CTD PMID:20080153 methapyrilene affects methylation ISO RGD:733836 6480464 Methapyrilene affects the methylation of GTF2IRD1 intron CTD PMID:30157460 N-methylformamide affects expression EXP 6480464 methylformamide affects the expression of GTF2IRD1 mRNA, methylformamide analog affects the expression of GTF2IRD1 mRNA CTD PMID:17040096 oxaliplatin multiple interactions ISO RGD:620856 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GTF2IRD1 mRNA CTD PMID:25729387 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of GTF2IRD1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:620856 6480464 Acetaminophen results in decreased expression of GTF2IRD1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:733836 6480464 Acetaminophen results in increased expression of GTF2IRD1 mRNA CTD PMID:29067470 perfluorononanoic acid increases expression ISO RGD:733836 6480464 perfluoro-n-nonanoic acid results in increased expression of GTF2IRD1 mRNA CTD PMID:32588087 phenobarbital increases expression ISO RGD:620856 6480464 Phenobarbital results in increased expression of GTF2IRD1 mRNA CTD PMID:19162173 phenylmercury acetate decreases expression ISO RGD:733836 6480464 Phenylmercuric Acetate results in decreased expression of GTF2IRD1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733836 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GTF2IRD1 mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of GTF2IRD1 mRNA CTD PMID:17426115 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of GTF2IRD1 mRNA CTD PMID:18301758 , PMID:23811191 piroxicam decreases expression ISO RGD:733836 6480464 Piroxicam results in decreased expression of GTF2IRD1 mRNA CTD PMID:21858171 potassium chromate decreases expression ISO RGD:733836 6480464 potassium chromate(VI) results in decreased expression of GTF2IRD1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:733836 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GTF2IRD1 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:620856 6480464 Pregnenolone Carbonitrile results in increased expression of GTF2IRD1 mRNA CTD PMID:19162173 progesterone increases expression ISO RGD:733836 6480464 Progesterone results in increased expression of GTF2IRD1 mRNA CTD PMID:18037150 rotenone increases expression ISO RGD:733836 6480464 Rotenone results in increased expression of GTF2IRD1 mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:733836 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases methylation ISO RGD:733836 6480464 Asbestos, Serpentine results in decreased methylation of GTF2IRD1 promoter CTD PMID:29626692 silver atom decreases expression EXP 6480464 Silver results in decreased expression of GTF2IRD1 mRNA CTD PMID:27131904 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of GTF2IRD1 mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:733836 6480464 sodium arsenite results in increased expression of GTF2IRD1 mRNA CTD PMID:29301061 , PMID:32844245 sodium arsenite decreases methylation ISO RGD:733836 6480464 sodium arsenite results in decreased methylation of GTF2IRD1 intron CTD PMID:32844245 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of GTF2IRD1 mRNA CTD PMID:27862939 sunitinib increases expression ISO RGD:733836 6480464 Sunitinib results in increased expression of GTF2IRD1 mRNA CTD PMID:31533062 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of GTF2IRD1 mRNA CTD PMID:20937368 tanespimycin multiple interactions ISO RGD:733836 6480464 [tanespimycin co-treated with VER 155008] results in decreased expression of GTF2IRD1 protein CTD PMID:31370342 tert-butyl hydroperoxide decreases expression ISO RGD:733836 6480464 tert-Butylhydroperoxide results in decreased expression of GTF2IRD1 mRNA CTD PMID:15336504 tetrachloromethane multiple interactions ISO RGD:620856 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GTF2IRD1 mRNA] CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:620856 6480464 Carbon Tetrachloride results in increased expression of GTF2IRD1 mRNA CTD PMID:31150632 topotecan multiple interactions ISO RGD:620856 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GTF2IRD1 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO RGD:733836 6480464 trichostatin A results in decreased expression of GTF2IRD1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:733836 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GTF2IRD1 mRNA CTD PMID:27188386 triptonide affects expression EXP 6480464 triptonide affects the expression of GTF2IRD1 mRNA CTD PMID:33045310 triptonide decreases expression EXP 6480464 triptonide results in decreased expression of GTF2IRD1 mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of GTF2IRD1 mRNA CTD PMID:28973697 urethane decreases expression ISO RGD:733836 6480464 Urethane results in decreased expression of GTF2IRD1 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:733836 6480464 Valproic Acid results in increased expression of GTF2IRD1 mRNA CTD PMID:29154799 valproic acid increases methylation ISO RGD:733836 6480464 Valproic Acid results in increased methylation of GTF2IRD1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:733836 6480464 Valproic Acid affects the expression of GTF2IRD1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:733836 6480464 Valproic Acid results in decreased expression of GTF2IRD1 mRNA CTD PMID:23179753 , PMID:26272509 valproic acid multiple interactions ISO RGD:733836 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GTF2IRD1 mRNA CTD PMID:27188386 vinclozolin increases methylation ISO RGD:620856 6480464 vinclozolin results in increased methylation of GTF2IRD1 gene CTD PMID:31682807 vitamin E decreases expression ISO RGD:733836 6480464 Vitamin E results in decreased expression of GTF2IRD1 mRNA CTD PMID:19244175 zoledronic acid decreases expression ISO RGD:733836 6480464 zoledronic acid results in decreased expression of GTF2IRD1 mRNA CTD PMID:24714768